SDGR

Schrödinger, Inc.

Technology · $2.3B market cap

Verdict

We can't put a fair value on SDGR right now. Its earnings are too small compared with its share price for an earnings-based value to mean anything.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-10.4% a year✗
Sales growth24.3% a year✓
Free cash flow growth-2.6% a year✗
Return on invested capital-29.0%✗

Follow SDGR

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds SDGR. Who we track

About Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery…

Software - Application

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works